Cargando…
Ivabradine: A Potential Therapeutic for Children With Refractory SVT
Background: In April 2015, ivabradine was approved by the Food and Drug Administration for the treatment of patients with coronary artery disease and heart failure (HF). The use of this medication has been linked with improved clinical outcomes and reduced rates of hospitalization in patients with s...
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8368123/ https://www.ncbi.nlm.nih.gov/pubmed/34414216 http://dx.doi.org/10.3389/fcvm.2021.660855 |